Sulfuric Acid

Sulfuric Acid

SCHEMBL4016436

CNCC(=O)c1cccc(O)c1.O=S(=O)(O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 1/20 0.38
ADRB1 known ✓ P08588 1/20 0.38
ADRA2A known ✓ P08913 1/20 0.38
ADRB3 known ✓ P13945 1/20 0.38
ADRA2B known ✓ P18089 1/20 0.38
ADRA2C known ✓ P18825 1/20 0.38
ADRA1A known ✓ P35348 1/20 0.38
ADRA1B known ✓ P35368 1/20 0.38
SLC6A3 known ✓ Q01959 1/20 0.38
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 2/20 0.49
EGLN2 Q96KS0 1/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA12 O43570 1/20 0.46
CA6 P23280 1/20 0.46
CA9 Q16790 1/20 0.46
PARP1 P09874 1/20 0.44
GAA P10253 2/20 0.43
POLB P06746 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1274658 0.93 KDM4E (0.55) KDM4EALDH1A1EGLN2CA1CA2
SCHEMBL29757148 0.93 KDM4E (0.55) KDM4EALDH1A1EGLN2CA1CA2
Hydrochloric Acid SCHEMBL31491126 0.92 KDM4E (0.53) KDM4EALDH1A1EGLN2CA1CA2
Hydrochloric Acid SCHEMBL4734485 0.92 KDM4E (0.53) KDM4EALDH1A1EGLN2CA1CA2
SCHEMBL10481543 0.78 ERCC5 (0.60) KDM4EALDH1A1PARP1POLBMAPT
SCHEMBL7446526 0.77 KDM4E (0.51) KDM4EALDH1A1EGLN2CA1CA2
SCHEMBL24229642 0.76 HDAC8 (0.55) KDM4EPARP1POLBMAPTCTNNB1
Sulfuric Acid SCHEMBL20838235 0.75 CA12 (0.55) KDM4EALDH1A1EGLN2CA1CA2
Hydrochloric Acid SCHEMBL11756049 0.75 KDM4E (0.50) KDM4EALDH1A1EGLN2CA1CA2
SCHEMBL2292351 0.75 CES2 (0.55) KDM4EALDH1A1PARP1MAPTCTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118016943-A High-energy-density alkaline iron-sulfur flow battery and preparation method thereof 北京民利储能技术有限公司 2024-05-10 CN claimed
US-12480100-B2 Ketoreductase polypeptides for the preparation of phenylephrine CODEXIS, INC. (US) 2025-11-25 US disclosed
US-20240301366-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE CODEXIS INC (US) 2024-09-12 US disclosed
US-12031159-B2 Ketoreductase polypeptides for the preparation of phenylephrine CODEXIS, INC. (US) 2024-07-09 US disclosed
CN-118016943-A High-energy-density alkaline iron-sulfur flow battery and preparation method thereof 北京民利储能技术有限公司 2024-05-10 CN disclosed
US-20220267744-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2022-08-25 US disclosed
US-11345898-B2 Ketoreductase polypeptides for the preparation of phenylephrine CODEXIS, INC. (US) 2022-05-31 US disclosed
US-20210062162-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2021-03-04 US disclosed
US-10870835-B2 Ketoreductase polypeptides for the preparation of phenylephrine CODEXIS, INC. (US) 2020-12-22 US disclosed
US-20200157511-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2020-05-21 US disclosed
US-10358631-B2 Ketoreductase polypeptides for the preparation of phenylephrine CODEXIS, INC. (US) 2019-07-23 US disclosed
US-20180066239-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2018-03-08 US disclosed
EP-2467473-B1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE CODEXIS INC (US) 2016-03-23 EP disclosed
US-9102959-B2 Ketoreductase polypeptides for the preparation of phenylephrine CODEXIS, INC. (US) 2015-08-11 US disclosed
US-20120149073-A1 Ketoreductase Polypeptides for the Preparation of Phenylephrine CODEXIS, INC. (US) 2012-06-14 US disclosed
WO-2009086283-A1 SYNTHESIS OF ENANTIOMERICALLY PURE 2-HYDROXY-2-ARYL-ETHYLAMINES CAMBREX CHARLES CITY, INC. (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12031159-B2 Ketoreductase polypeptides for the preparation of phenylephrine AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-20220267744-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-20180066239-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-20210062162-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-20200157511-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-10870835-B2 Ketoreductase polypeptides for the preparation of phenylephrine AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-12480100-B2 Ketoreductase polypeptides for the preparation of phenylephrine AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-20240301366-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PREPARATION OF PHENYLEPHRINE AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-10358631-B2 Ketoreductase polypeptides for the preparation of phenylephrine AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885
US-11345898-B2 Ketoreductase polypeptides for the preparation of phenylephrine AKR1B1, AKR1A1, AKR1C2 ADRB2 50/4885ADRB1 34/4885ADRA2A 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.